Search for: "A B" Results 6901 - 6920 of 155,574
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Jul 2017, 10:52 am by Angel Reyes III
Recalled clips include the ones on B-Safe 35, B-Safe 35 Elite, BOB B-Safe 35 infant seats, and accompanying travel systems, all manufactured between November 2015 and May 2017. [read post]
2 Apr 2012, 3:59 pm
The company made the following disclosure regarding the purported $9.79/share book value of the Class B and C common stock shares: In connection with the Conversion Transactions, we issued 3,811,342 shares of Class B-1 common stock, 3,811,342 shares of Class B-2 common stock, 7,721,055 shares of Class B-3 common stock, 627,579 shares of Class B-4 common stock and 838,448 shares of Class C common stock. [read post]
13 Jun 2011, 12:24 pm by PaulKostro
Ordover, Balancing The Presumptions Of Guilt And Innocence: Rules 404(b), 608(b), And 609(a), 38 Emory L.J. 135, 160 (1989)).] [read post]
4 May 2020, 8:07 am by Aida Geragusian
Legal question B brought a claim against Yodel, claiming worker status for the purpose of the WTR. [read post]
16 Mar 2012, 3:03 pm
O ministro Luiz Fux, do Supremo Tribunal Federal (STF), manteve a prisão preventiva do cidadão búlgaro G.P.B., ex-atleta olímpico no levantamento de peso, que foi preso em flagrante delito no dia 24 de outubro do ano passado no aeroporto de Guarulhos (SP), quando pretendia deixar o Brasil levando nove quilos de cocaína na bagagem. [read post]
10 Feb 2015, 10:26 am
"We hold that Comcast does not mandate that certification pursuant to Rule 23(b)(3) requires a finding that damages are capable of measurement on a classwide basis. [read post]
17 Nov 2017, 7:29 am by Docket Navigator
Even if the TC Heartland decision was an intervening change in law, the 'omission of improper venue from [a party]⁠'s first 12(b) motion constitutes a "procedural misstep,"' which precludes a party from '"invok[ing] intervening Supreme Court case law" in order to "correct" it.'. . . [read post]
22 Nov 2011, 1:00 pm by Steven Kaufhold
In support of the decision below, Simmonds argues that Section 16(b) works in tandem with Section 16(a) and that “Section 16(b) enforcement requires Section 16(a) disclosure. [read post]
19 Jun 2012, 7:44 pm by FDABlog HPM
  Under FDA’s evolving thinking around 505(b)(2) applications, however, an ANDA can no longer be cited as a listed drug in a 505(b)(2) application. [read post]
6 Sep 2011, 4:00 pm by FDABlog HPM
  But even if so, FDA cannot make the same case for § 505(b)(2) drugs because the elements of a TE evaluation cannot be found in § 505(b)(2) (or any other statutory provision applicable to § 505(b)(2) drugs). [read post]